Multidrug-resistant gram-negative infections (MDRGNIs) are an emerging and deadly threat worldwide. Some of these infections are now resistant to nearly all antibiotics, and very few treatment options ...

The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, ...

Hospital uptake of newer antibiotics to treat multidrug-resistant gram-negative bacteria was low over a 5-year period, according to a retrospective cohort study. Fully 41.5% of episodes of ...

Please provide your email address to receive an email when new articles are posted on . Gram-negative bacteria comprise most of the CDC and WHO’s lists of critical and urgent antibiotic-resistant ...

EDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting four posters at the ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...

Please provide your email address to receive an email when new articles are posted on . “What antibiotic should I use to treat this patient’s Klebsiella pneumoniae? It’s resistant to carbapenems, and ...

HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (“Appili”), an anti-infective drug development company, announced today that it will be receiving an additional $400,000 from the ...

ORLANDO, FL, UNITED STATES, January 27, 2026 /EINPresswire.com/ — Orakle LLC is pleased to announce the launch of a new series of CME-accredited, case-based ...

Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial ...

Infections caused by gram-negative bacteria have features that are of particular concern. These organisms are highly efficient at up-regulating or acquiring genes that code for mechanisms of ...